New technology infuses drugs directly into the brain for Alzheimer's patients

The Israeli Institute of Technology (Technion) said on November 17 that Israeli researchers have developed a new technology to inject drugs directly into the brain for Alzheimer's patients using silicon chips.

These tiny silicon billionths of a meter will provide an important protein that can curb disease development.

The findings were made by researchers from Technion and Bar-Ilan University and published in the Small Daily newspaper.

The chips provide an important protein to curb disease development.

Alzheimer's disease manifests itself as dementia, poor language, poor movement, many orientation problems .

This disease is common in the elderly, due to the persistent degeneration of the brain, resulting from the transport of proteins in brain tissues that kill nerve tissues and damage important mechanisms for brain function.

Providing special proteins will prevent this, but getting the proteins into the right areas of the brain is not a simple task because of the barrier between the blood vessels. This barrier is originally meant to protect the central nervous system from bacteria and harmful substances, but also prevents the movement of drugs.

The team's solution is to introduce the protein into the brain and release it to the central cell using tiny microchip chips, allowing them to carry large amounts of protein.

The chip is inserted into the brain by a "gun gene," a system that releases metal particles filled with these molecules.